The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum

September 22, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., Sept. 22 /- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced that Joanna Horobin, M.D., the company's president and CEO, will present at the Sachs Biotech in Europe Investor Forum Wednesday, September 29, 2010 at the Radisson Blu...


Federal Register: Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices Third-Party Review Under the Food and Drug Administration Mod...

September 22, 2010 6:30 am | by U.S. Food & Drug Administration | News | Comments

The FDA is announcing an opportunity for public comment on the proposed collection of certain information by the agency.


Poster Highlights First Randomized Controlled Trial Comparing Market Leading Kinetic Concepts, Inc. Wound V.A.C.(R) System to Spiracur(R) SNaP(R) Wound Care System for Treatment of...

September 22, 2010 5:45 am | by The Associated Press | News | Comments

Leading wound care experts will present a Poster highlighting results from a multicenter randomized controlled trial (RCT) comparing negative pressure wound therapy (NPWT) between the SNaP@ Wound Care System from Spiracur, Inc., of Sunnyvale, Calif., and the Wound V.A.C.@ Therapy System...


Dr. Brian Boxer Wachler to be Honored With Olympic Gold Medal Bobsled Champion Steve Holcomb Alongside Apple CEO Steve Jobs, James Cameron, Dan Rather, Quincy Jones and Others...

September 22, 2010 5:31 am | by Bio-Medicine.Org | News | Comments

BEVERLY HILLS, Calif., Sept. 22 /- After ten years of dedication to developing new, innovative treatments to help patients with Keratoconus, a degenerative eye disease that affects millions of people worldwide and can cause severe loss of vision, Dr. Brian S. Boxer Wachler, MD is to...


Biomatrica Launches DNAgard® Blood and DNAstable Blood for Stabilization, Storage and Shipping of Whole Blood at Room Temperature

September 22, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 22 /- Biomatrica Inc., the leader in room temperature biological sample stabilization, today announced the release of DNAgard® Blood and DNAstable® Blood. DNAgard® Blood is a new addition to the "Gard" product line for the stabilization and shipping of...


Aeras and Crucell announce Phase II clinical trial start in Kenya

September 22, 2010 12:31 am | by EurekAlert | News | Comments

(Aeras Global TB Vaccine Foundation) Aeras and Crucell announce the start of a Phase II clinical trial in infants of the jointly developed TB vaccine candidate, AERAS-402/Crucell Ad35. The trial will test the safety and efficacy of the TB vaccine candidate in infants previously vaccinated...


Novartis Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushing's Disease, a Debilitating Hormonal Disorder

September 21, 2010 11:32 pm | by Bio-Medicine.Org | News | Comments

EAST HANOVER, N.J., Sept. 22 /- Novartis Pharmaceuticals Corporation ("Novartis") (NYSE: NVS ) announced today that the results of a Phase III study of SOM230 (pasireotide) showed a reduction in cortisol levels in patients with Cushing's disease, a condition in which a benign...


NIH celebrates 10 years of research into health disparities

September 21, 2010 1:32 pm | by EurekAlert | News | Comments

(NIH/National Heart, Lung and Blood Institute) The tenth anniversary of the Jackson Heart Study (JHS) will be observed on Sept. 23-24 in Jackson, Mississippi. The JHS is the largest study in history to investigate genetic factors that affect high blood pressure, heart and lung disease,...


Drink milk and lose more weight, according to Ben-Gurion University of the Negev research

September 21, 2010 12:34 pm | by EurekAlert | News | Comments

(American Associates, Ben-Gurion University of the Negev) BGU researchers reveals that dieters who consumed milk or milk products lost more weight on average than those who consumed little to no milk products. Researchers also found participants with the highest dairy calcium...


Boston Scientific Announces Clinical Data Supporting Safety and Efficacy of Platinum Chromium PROMUS Element™ Stent

September 21, 2010 12:31 pm | by Boston Scientific | News | Comments

Nine-month results from PLATINUM clinical program presented at TCT


Reportlinker Adds IP Overview - "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010

September 21, 2010 12:31 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 21 /- announces that a new market research report is available in its catalogue: IP Overview – "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010...


New therapy found for lung and skin cancer, based on suicide gene E

September 21, 2010 12:31 pm | by EurekAlert | News | Comments

(University of Granada) This coliphage gene can induce death to cells transected with it. Scientists at the University of Granada have proven that this method is not only effective in vitro (using tumor cell cultures), but also in vivo, through the use of experimental animals in which...


In-Molding the Details

September 21, 2010 11:47 am | by Al Hoeschele and Todd Geisser | Articles | Comments

Providing easy to follow instructions on a medical device can be a significant challenge; when coupled with ensuring the solution does not create cleaning concerns and will not wear, that obstacle to success becomes even greater. This article examines the benefits of in-mold decorating/labeling for medical devices and how they resolve these, and other, challenges.

Data show clinical benefit from mitral valve clip device

September 21, 2010 11:36 am | by EurekAlert | News | Comments

(Cardiovascular Research Foundation) A percutaneous mitral valve clip designed to stop mitral valve regurgitation demonstrated clinical benefit as measured by the degree of mitral regurgitation, according to a study presented at the 22nd annual Transcatheter Cardiovascular...


Study examines use of stent with bioabsorbable polymer

September 21, 2010 11:36 am | by EurekAlert | News | Comments

(Cardiovascular Research Foundation) Three-year data demonstrated that satisfactory clinical and safety outcomes of sirolimus eluting stents with a biodegradable polymer were sustained in a real world setting. The results were presented at the 22nd annual Transcatheter...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.